Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Aug;72(2 Suppl):S73–S79. doi: 10.1136/hrt.72.2_suppl.s73

Optimising heart failure pharmacotherapy: the ideal combination

John G F Cleland 1, David P Dutka 1
PMCID: PMC1025581  PMID: 7946765

Full text

PDF
S73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ang E. L., Chan W. L., Cleland J. G., Moore D., Krikler S. J., Alexander N. D., Oakley C. M. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. Br Heart J. 1990 Oct;64(4):256–260. doi: 10.1136/hrt.64.4.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cleland J. G. Ancillary diagnostic and therapeutic issues in cardiac failure. Curr Opin Cardiol. 1992 Jun;7(3):408–415. doi: 10.1097/00001573-199206000-00009. [DOI] [PubMed] [Google Scholar]
  3. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleland J. G., Henderson E., McLenachan J., Findlay I. N., Dargie H. J. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol. 1991 Mar 1;17(3):733–739. doi: 10.1016/s0735-1097(10)80192-5. [DOI] [PubMed] [Google Scholar]
  6. Cleland J. G., Oakley C. M. Vascular tone in heart failure: the neuroendocrine-therapeutic interface. Br Heart J. 1991 Oct;66(4):264–267. doi: 10.1136/hrt.66.4.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cody R. J., Torre S., Clark M., Pondolfino K. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Arch Intern Med. 1989 May;149(5):1023–1028. [PubMed] [Google Scholar]
  8. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  9. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  10. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  11. Cohn J. N. Statistical significance of Veterans Administration Vasodilator Heart Failure Trial results. Am J Cardiol. 1990 Dec 15;66(20):1507–1508. doi: 10.1016/0002-9149(90)90544-b. [DOI] [PubMed] [Google Scholar]
  12. Cowley A. J., Wynne R. D., Swami A., Birkhead J., Skene A., Hampton J. R. A comparison of the effects of captopril and flosequinan in patients with severe heart failure. Cardiovasc Drugs Ther. 1992 Oct;6(5):465–470. doi: 10.1007/BF00055602. [DOI] [PubMed] [Google Scholar]
  13. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R. C., Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–683. doi: 10.1056/NEJM198903163201101. [DOI] [PubMed] [Google Scholar]
  14. Feldman A. M., Bristow M. R., Parmley W. W., Carson P. E., Pepine C. J., Gilbert E. M., Strobeck J. E., Hendrix G. H., Powers E. R., Bain R. P. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15;329(3):149–155. doi: 10.1056/NEJM199307153290301. [DOI] [PubMed] [Google Scholar]
  15. Goldbourt U., Behar S., Reicher-Reiss H., Zion M., Mandelzweig L., Kaplinsky E. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med. 1993 Feb 8;153(3):345–353. [PubMed] [Google Scholar]
  16. Goldstein R. E., Boccuzzi S. J., Cruess D., Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation. 1991 Jan;83(1):52–60. doi: 10.1161/01.cir.83.1.52. [DOI] [PubMed] [Google Scholar]
  17. Gosselink A. T., Crijns H. J., Van Gelder I. C., Hillige H., Wiesfeld A. C., Lie K. I. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA. 1992 Jun 24;267(24):3289–3293. [PubMed] [Google Scholar]
  18. Hall D., Zeitler H., Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol. 1992 Dec;20(7):1549–1555. doi: 10.1016/0735-1097(92)90449-w. [DOI] [PubMed] [Google Scholar]
  19. Kiyingi A., Field M. J., Pawsey C. C., Yiannikas J., Lawrence J. R., Arter W. J. Metolazone in treatment of severe refractory congestive cardiac failure. Lancet. 1990 Jan 6;335(8680):29–31. doi: 10.1016/0140-6736(90)90148-x. [DOI] [PubMed] [Google Scholar]
  20. Lerman A., Gibbons R. J., Rodeheffer R. J., Bailey K. R., McKinley L. J., Heublein D. M., Burnett J. C., Jr Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 1993 May 1;341(8853):1105–1109. doi: 10.1016/0140-6736(93)93125-k. [DOI] [PubMed] [Google Scholar]
  21. Levine J. H., Mellits E. D., Baumgardner R. A., Veltri E. P., Mower M., Grunwald L., Guarnieri T., Aarons D., Griffith L. S. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation. 1991 Aug;84(2):558–566. doi: 10.1161/01.cir.84.2.558. [DOI] [PubMed] [Google Scholar]
  22. Lewis G. R. Lisinopril versus placebo in older congestive heart failure patients. Am J Med. 1988 Sep 23;85(3B):48–54. doi: 10.1016/0002-9343(88)90351-8. [DOI] [PubMed] [Google Scholar]
  23. O'Neill C. J., Bowes S. G., Sullens C. M., Royston J. P., Hunt W. B., Denham M. J., Dobbs R. J., Dobbs S. M. Evaluation of the safety of enalapril in the treatment of heart failure in the very old. Eur J Clin Pharmacol. 1988;35(2):143–150. doi: 10.1007/BF00609243. [DOI] [PubMed] [Google Scholar]
  24. O'Neill C. J., Charlett A., Dobbs R. J., Deshmukh A. A., Bowes S. G., Weller C., Nicholson P. W., Milledge J. S., Dobbs S. M. Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients. Br J Clin Pharmacol. 1992 Feb;33(2):167–178. doi: 10.1111/j.1365-2125.1992.tb04020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  26. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  27. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  28. Pouleur H., Rousseau M. F., Oakley C., Rydén L. Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol. 1991 Jul 1;68(1):71–74. doi: 10.1016/0002-9149(91)90713-u. [DOI] [PubMed] [Google Scholar]
  29. Smith P., Arnesen H., Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990 Jul 19;323(3):147–152. doi: 10.1056/NEJM199007193230302. [DOI] [PubMed] [Google Scholar]
  30. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990 Nov;82(5):1730–1736. doi: 10.1161/01.cir.82.5.1730. [DOI] [PubMed] [Google Scholar]
  31. Waagstein F., Caidahl K., Wallentin I., Bergh C. H., Hjalmarson A. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation. 1989 Sep;80(3):551–563. doi: 10.1161/01.cir.80.3.551. [DOI] [PubMed] [Google Scholar]
  32. Wieshammer S., Hetzel M., Hetzel J., Kochs M., Hombach V. Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated with captopril. Br Heart J. 1993 Jul;70(1):17–21. doi: 10.1136/hrt.70.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Woodley S. L., Gilbert E. M., Anderson J. L., O'Connell J. B., Deitchman D., Yanowitz F. G., Mealey P. C., Volkman K., Renlund D. G., Menlove R. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991 Dec;84(6):2426–2441. doi: 10.1161/01.cir.84.6.2426. [DOI] [PubMed] [Google Scholar]
  34. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group. Lancet. 1990 Jul 7;336(8706):1–6. [PubMed] [Google Scholar]
  35. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES